SYN-TECH Chem. & Pharm. Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
November 06, 2023 at 05:33 pm EST
Share
SYN-TECH Chem. & Pharm. Co., Ltd. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was TWD 330.37 million compared to TWD 281.81 million a year ago. Net income was TWD 92.48 million compared to TWD 113.33 million a year ago. Basic earnings per share from continuing operations was TWD 2.07 compared to TWD 2.54 a year ago. Diluted earnings per share from continuing operations was TWD 2.07 compared to TWD 2.54 a year ago.
For the nine months, sales was TWD 842.79 million compared to TWD 738.25 million a year ago. Net income was TWD 225.54 million compared to TWD 271.99 million a year ago. Basic earnings per share from continuing operations was TWD 5.06 compared to TWD 6.1 a year ago. Diluted earnings per share from continuing operations was TWD 5.05 compared to TWD 6.09 a year ago.
SYN-TECH Chem. & Pharm. Co., Ltd. is a Taiwan-based company principally engaged in the production, processing and distribution of active pharmaceutical ingredients (APIs). The Companyâs main products consist of muscle relaxants, local anesthetics, cardiovascular agents, antipyretics, analgesics and anti-inflammatory drugs, antimicrobials, spirit stabilizers, intermediates and others. It is also engaged in the pharmaceutical agency business. The Company distributes its products within Taiwan market and to overseas markets, including Asia, Europe, the Americas and Africa.
SYN-TECH CHEM. & PHARM. CO., LTD. 
